Cognition Therapeutics, Inc. (CGTX) Net income 2021–2026
Cognition Therapeutics, Inc. (CGTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$23.5MFY2026 · since FY2021: -$7.8M → -$23.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$23.5M | +30.9% |
| FY2025 | -$34.0M | -31.7% |
| FY2024 | -$25.8M | -20.5% |
| FY2023 | -$21.4M | -82.6% |
| FY2022 | -$11.7M | -49.5% |
| FY2021 | -$7.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice